BENJAMIN OLIVER: Open Payments
NPI 1992202840 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 19 payments from 7 companies in 2025. Trend: 2023 $1,645 · 2024 $1,039 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $234 |
| PFIZER INC. | 4 | $164 |
| Aimmune Therapeutics, Inc. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Mauna Kea Technologies, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: XELJANZ, SKYRIZI, ZENPEP, RINVOQ, DUPIXENT, VELSIPITY, LINZESS, MAVYRET.
Industry payments across GA — which companies pay providers there.
